Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lange, Christian M ^a,b   Miki, Daiki ^c,d   Ochi, Hidenori ^c,d   Nischalke, Hans Dieter ^e   Bojunga, Jörg ^b   Bibert, Stéphanie ^a   Morikawa, Kenichi ^a   Gouttenoire, Jérôme ^a   Cerny, Andreas ^f,q   Dufour, Jean François ^g,q   Gorgievski Hrisoho, Meri ^h   Heim, Markus H ⁱ   Malinverni, Raffaele ^j,q   Müllhaupt, Beat ^k,q   Negro, Francesco ^l,q   Semela, David ^m,q   Kutalik, Zoltan ⁿ   Müller, Tobias ^o   Spengler, Ulrich ^e   Berg, Thomas ^p   Chayama, Kazuaki ^c,d   Moradpour, Darius ^a,q   Bochud, Pierre Yves ^a   Hadengue, Antoine ^q   Kaiser, Laurent ^q   Rubbia Brandt, Laura ^q   Cellerai, Cristina ^q   Rickenbach, Martin ^r   Martinetti, Gladys ^q   Gorgievski, Meri ^q   Spicher, Virginie Masserey ^q   Heim, Markus ^q   Hirsch, Hans ^q   Helbling, Beat ^q   Regenass, Stephan ^q   Dollenmaier, Guenter ^q   Cathomas, Gieri ^q   more..

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c RIKEN   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF BONN   (Germany)

^f Ospedale Moncucco   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j Division of Gastroenterology Hôpital Neuchâtelois   (Switzerland)

^k UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^l GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^m Division of Gastroenterology and Hepatology   (Switzerland)

ⁿ UNIVERSITY OF LAUSANNE   (Switzerland)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^q Lausanne Data Center ^*

^r Lausanne Data Center   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PEGINTERFERON ALPHA; RIBAVIRIN; VITAMIN D;

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CYP2R1 GENE; DHCR7 GENE; FEMALE; GC GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHILD; CHOLESTANETRIOL 26-MONOOXYGENASE; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 84878436278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064053     Document Type: Article

References (21)

1. Nature Outlook, (2011) Hepatitis C. Nature. 474: S1-S21.
2. Forner A, Llovet JM, Bruix J, (2012) Hepatocellular carcinoma. Lancet 371: 1245-55.
3. Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R, et al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43: 455-458.
4. Miki D, Ochi H, Hayes CN, Abe H, Yoshima T, et al. (2011) Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet 43: 797-800.
5. Campbell FC, Xu H, El-Tanani M, Crowe P, Bingham V, (2010) The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol 79: 1-9.
6. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
7. Rosen CJ, (2011) Clinical practice. Vitamin D insufficiency. N Engl J Med 364: 248-254.
8. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, et al. (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19: 2739-2745.
9. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180-188.
10. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, et al. (2011) Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 54: 887-893.
11. Prasad L, Spicher VM, Zwahlen M, Rickenbach M, Helbling B, et al. (2007) Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS). Int J Epidemiol 36: 731-737.
12. Nischalke HD, Coenen M, Berger C, Aldenhoff K, Muller T, et al. (2012) The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer. 130: 1470-1475.
13. Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, et al. (2009) Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol. 51: 655-666.
14. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138: 1338-1345.
15. Lange CM, Bibert S, Kutalik Z, Burgisser P, Cerny A, et al. (2012) A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS One. 7: e40159.
16. Chiang KC, Yeh CN, Chen MF, Chen TC, (2011) Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol 26: 1597-1603.
17. Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg KJ, et al. (2003) A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 89: 252-257.
18. Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, et al. (2010) Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol 16: 3016-3024.
19. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, et al. (2003) Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290: 476-485.
20. Bouillon R, Auwerx J, Dekeyser L, Fevery J, Lissens W, et al. (1984) Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 59: 86-89.
21. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, et al. (2010) Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 51: 1158-1167.